IBEX Innovations

IBEX Innovations Ltd is a private limited company based in Stockton-on-Tees, England, established in March 2010. The company focuses on manufacturing and research in natural sciences and engineering, particularly in developing medical products for osteoporosis diagnosis. Their core mission is to enhance access to early diagnosis of osteoporosis, aiming to create a world without fragility fractures. The company’s flagship product, the IBEX BH, utilizes advanced X-ray detector technology to facilitate routine osteoporosis diagnosis. IBEX Innovations holds multiple patents for its technology in various countries and is recognized for its registered trademarks, including “IBEX” and “IBEX TRUEVIEW.” The company is accredited to ISO 13485:2016 and complies with EU Medical Device Regulation standards, ensuring high-quality management systems. IBEX Innovations collaborates with several academic institutions and NHS Trusts, as well as leading osteoporosis charities. The company is supported by venture capital, corporate investors, and grants from InnovateUK and the European Union, reinforcing its commitment to research and development in the field of osteoporosis.

• Employees 19
• Founded 2010
• Annual Revenue $9000000
• Total Funding $8684476